MedPath

clinical comparative study of unani drug in chronic rhinosinusitis

Phase 2
Conditions
Health Condition 1: J329- Chronic sinusitis, unspecified
Registration Number
CTRI/2023/04/051601
Lead Sponsor
State Unani Medical College Prayagraj
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1 Patients fulfilling AAO-HNS criteria that is at least two major criteria

(Nasal obstruction or blockage, anterior or posterior nasal discharge, Facial pain /congestion, Purulence in a nasal cavity on examination, Anosmia/ Hyposmia) or one major and two minor criteria (Halitosis, earache, dental pain, cough, fatigue)

2 patients had an opacity of X-ray paranasal sinuses (waters view) ranging from +1 (Mucosal thickening) to +3 (complete opaque antrum) grading.

3 Patients of either sex.

4 Patients in the age group of 18 to 60 years.

5 Patients with involvement of any sinus.

6 Those who give written consent.

Exclusion Criteria

1 Child below 18 years of age.

2 Patients above 60 years of age.

3 Pregnant & lactating mothers.

4 Patients who fail to give consent.

5 Patients who fail to follow up.

6 Mentally retarded persons.

7 Patients with Malignancy of the nose or paranasal sinuses.

8 Patients have a history of any surgery of the nose or paranasal sinuses.

9 Patients have a history of any foreign body in their nose.

3Patient have a history of trauma to the nose or sinus areas.

10 Patients suffering from any congenital or acquired structural abnormality of the nasal cavity.

11 Any medical condition where the physician feels that participation in the study could be detrimental to patientsÂ? wellbeing.

12 Patients of pulmonary Kochs or patients having history of epistaxis

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath